
t24.com.tr
Record-Breaking 100+ Day Survival Achieved with BiVACOR Artificial Heart
A 40-year-old Australian with heart failure survived over 100 days with a BiVACOR artificial heart before receiving a donor heart, setting a new world record for this technology and showing potential for long-term use in organ transplant patients.
Turkish
Turkey
TechnologyScienceSpace ExplorationFood TechnologyQuantum TechnologyScientific BreakthroughsArtificial HeartDinozor
BivacorNasaSpacexQiaÇin Teknoloji Ve Bilim ÜniversitesiCalgary ÜniversitesiOhio State Üniversitesi
Butch WilmoreSuni Williams
- What is the global significance of the record-breaking survival of a patient using the BiVACOR artificial heart?
- A 40-year-old Australian with heart failure survived for over 100 days with a titanium artificial heart, the BiVACOR, before a donor heart became available. This is a world record for survival with this type of device. The BiVACOR mimics the blood flow of a healthy heart using magnetic levitation technology.
- What are the potential future technological advancements that could improve or expand upon the success of the BiVACOR?
- The BiVACOR's success could accelerate research and development of artificial organs. Further breakthroughs in biocompatible materials and power sources could lead to permanently implantable devices, potentially transforming healthcare and extending human lifespan. The technology's future impact on healthcare systems and patient care is considerable.
- How does the BiVACOR artificial heart work, and what are its potential long-term implications for organ transplant waiting lists?
- The successful use of the BiVACOR artificial heart highlights advancements in extending life for patients awaiting organ transplants. The 100+ day survival demonstrates the potential for longer-term use, offering hope to those on transplant waiting lists. This technology could significantly reduce mortality rates for patients with end-stage heart failure.
Sustainable Development Goals
Good Health and Well-being Very Positive
Direct Relevance
The development and successful implementation of the BiVACOR artificial heart represents a significant advancement in healthcare, providing a lifeline for patients awaiting organ transplants and potentially improving their quality of life and longevity. The 100+ days survival with the artificial heart is a major breakthrough.